<sup>161</sup>Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of<sup>161</sup>Tb into the Clinic-Reference-Cited by-同舟云学术

¹⁶¹Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of¹⁶¹Tb into the Clinic

Published:2023-05-18 Issue:7 Volume:64 Page:1138-1144
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Favaretto Chiara,Grundler Pascal V.,Talip Zeynep,Landolt Stefan,Sepini Lebogang,Köster Ulli,Müller Cristina,Schibli Roger,Geistlich Susanne,van der Meulen Nicholas P.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference39 articles.

1. Gastroenteropancreatic neuroendocrine tumours

2. Indications of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic and pulmonary neuroendocrine tumors: an updated review;Camus;J Clin Med.,2021

3. Lutetium-labelled peptides for therapy of neuroendocrine tumours

4. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

5. Committee for Medicinal Products for Human Use. Assessment Report: Lutathera. European Medicines Agency; 2017:1–132. EMA/506460/2017.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terbium-149 production: a focus on yield and quality improvement towards preclinical application;Scientific Reports;2024-02-08

2. Radiolabelled ¹⁷⁷Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers;Chemistry – A European Journal;2024-01-17

3. Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb;Médecine Nucléaire;2023-11

4. Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics;European Journal of Nuclear Medicine and Molecular Imaging;2023-07-12